| Age at the time of transplant (years) |
61.5 ± 7 years |
| Male sex |
13 (59.1%) |
|
Race/ethnicity
|
n
(%)
|
| Caucasian |
11 (50) |
| African American |
9 (40.1) |
| Latino |
2 (9.1) |
|
Body mass index (BMI, in kg/m
2
)
|
29.5 ± 4.5 |
|
Comorbidities
|
n
(%)
|
| Peripheral artery disease |
22 (100) |
| Hypertension |
21 (95.5) |
| Diabetes mellitus |
14 (63.6) |
| Coronary artery disease |
10 (45.5) |
| Hyperlipidemia |
7 (31.8) |
| Chronic pulmonary obstructive Disease |
2 (9.1) |
|
Medication
|
n
(%)
|
| Acetylsalicylic acid |
19 (86.4) |
| Beta blockers |
15 (68.2) |
| Statins |
10 (45.5) |
| Calcium channel blockers |
10 (45.5) |
| Clopidogrel |
6 (27.3) |
| Anticoagulation medications |
4 (18.2) |
|
Etiology of end-stage renal disease
|
n
(%)
|
| Diabetes mellitus |
10 (45.5) |
| Diabetes/hypertension |
5 (22.7) |
| Hypertension |
3 (13.6) |
| Lupus nephritis |
1 (4.5) |
| Interstitial nephritis |
1 (4.5) |
| Proteinuric kidney disease |
1 (4.5) |
| Focal segmental Glomerulosclerosis |
1 (4.5) |
|
Type of kidney donor
|
n
(%)
|
| Deceased donor |
16 (72.7) |
| Living donor |
6 (27.3) |
| Preoperative computed tomography |
13 (59.1) |
| Preoperative serum creatinine (mg/dL) |
7.4 ± 2.6 |
